Ophthalmic composition containing recoflavone for the treatment of dry eye disease
AssigneeGl Pharmtech Corp.
InventorsEun Jung KIM, Jun Sang PARK
Life of this patent
Estimating the term…
Abstract
The present invention relates to an ophthalmic composition containing recoflavone for the treatment of dry eye disease. Specifically, in order to maximize the improvement of symptoms of dry eye, the present invention relates to an ophthalmic composition containing a certain concentration of the active ingredient and at least one of polyoxyethylene castor oil derivatives or poloxamers which are permeation enhancers, so that the active ingredient, recoflavone, can sufficiently penetrate the cornea in vivo to exhibit significant therapeutic effects.
Claims5
An ophthalmic composition for the treatment of dry eye disease, the composition comprising 5% (w/v) or more of recoflavone or a pharmaceutically acceptable salt thereof;
- and 0.1 to 5.0% (w/v) of polyoxyethylene castor oil derivative or poloxamer alone or in combination.
Dependencies are inferred from the claim text.